Search research articles
Contact Us
Filters
Showing results (11-20 of 85) with videos related to
Page
of 9
Sort By:
European Archives of Psychiatry and Clinical Neuroscience
|
August 28, 2012
Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders
Caroline Nothdurfter, Thomas C Baghai, Cornelius Schüle, et al.
Psychiatrische Praxis
|
April 5, 2011
[Cannabinoid-induced hyperemesis]
Martin Lieb, Ulrich Palm, Mathias Nicolaus, et al.
Neuroendocrinology
|
December 13, 2006
Neuroactive steroids in depression and anxiety disorders: clinical studies
Daniela Eser, Cornelius Schüle, Thomas C Baghai, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
July 9, 2008
Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study
Cornelius Schüle, Thomas C Baghai, Daniela Eser, et al.
Current Pharmaceutical Design
|
December 17, 2008
Neuroactive steroids as endogenous modulators of anxiety
Daniela Eser, Thomas C Baghai, Cornelius Schüle, et al.
Psychiatrische Praxis
|
January 12, 2012
[Ketamine-induced vesicopathy]
Martin Lieb, Markus Bader, Ulrich Palm, et al.
The American Journal of Psychiatry
|
June 4, 2008
Electroconvulsive therapy in a patient with concomitant depression and charcot-marie-tooth disease
Anna Laenger, Gregor Leicht, Cornelius Schule, et al.
Expert Review of Endocrinology & Metabolism
|
October 7, 2018
Neuroactive steroids as modulators of depression and anxiety
Daniela Eser, Elena Romeo, Thomas C Baghai, et al.
Journal of Psychiatric Research
|
August 19, 2008
Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients
Cornelius Schüle, Thomas C Baghai, Daniela Eser, et al.
Psychiatrische Praxis
|
September 1, 2011
[Antidepressants for mild depressive disorders]
Thomas C Baghai, Martin Lieb, Hans-Jürgen Möller, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 85) with videos related to
Sort By:
Page
of 9
European Archives of Psychiatry and Clinical Neuroscience
|
August 28, 2012
Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders
Caroline Nothdurfter, Thomas C Baghai, Cornelius Schüle, et al.
Psychiatrische Praxis
|
April 5, 2011
[Cannabinoid-induced hyperemesis]
Martin Lieb, Ulrich Palm, Mathias Nicolaus, et al.
Neuroendocrinology
|
December 13, 2006
Neuroactive steroids in depression and anxiety disorders: clinical studies
Daniela Eser, Cornelius Schüle, Thomas C Baghai, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
July 9, 2008
Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study
Cornelius Schüle, Thomas C Baghai, Daniela Eser, et al.
Current Pharmaceutical Design
|
December 17, 2008
Neuroactive steroids as endogenous modulators of anxiety
Daniela Eser, Thomas C Baghai, Cornelius Schüle, et al.
Psychiatrische Praxis
|
January 12, 2012
[Ketamine-induced vesicopathy]
Martin Lieb, Markus Bader, Ulrich Palm, et al.
The American Journal of Psychiatry
|
June 4, 2008
Electroconvulsive therapy in a patient with concomitant depression and charcot-marie-tooth disease
Anna Laenger, Gregor Leicht, Cornelius Schule, et al.
Expert Review of Endocrinology & Metabolism
|
October 7, 2018
Neuroactive steroids as modulators of depression and anxiety
Daniela Eser, Elena Romeo, Thomas C Baghai, et al.
Journal of Psychiatric Research
|
August 19, 2008
Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients
Cornelius Schüle, Thomas C Baghai, Daniela Eser, et al.
Psychiatrische Praxis
|
September 1, 2011
[Antidepressants for mild depressive disorders]
Thomas C Baghai, Martin Lieb, Hans-Jürgen Möller, et al.
Page
of 9